Getting a Handle on Prescription Drug Pricing – A Modestly Radical Proposal
By Kent Bernard Recently there has been a lot of discussion about the high cost of prescription drugs. Some of
By Kent Bernard Recently there has been a lot of discussion about the high cost of prescription drugs. Some of
By Jay L. Himes & Matthew J. Perez With the Antitrust Criminal Penalty Enhancement and Reform Act (“ACPERA”) set to
By Kyriakos Fountoukakos & Samuel Hall Competition Commissioner, Margrethe Vestager, has labelled digitization the “one big change that overshadows everything
By Vanesa Yanhua Zhang, John Jiong Gong & Amanda Jing Yang – In this paper, we analyze SAMR’s conditional approval
By Aaron M. Panner Antitrust doctrine provides that any justification for a restraint of trade must be couched in terms
August 2019 CPI Europe Column edited by Anna Tzanaki (Competition Policy International) & Juan Delgado (Global Economics Group) presents: European Competition Policy in Digital:
Dear Readers, The July 2019 CPI Antitrust Chronicle® features articles on vertical mergers with a focus on the AT&T/Time Warner
…with Bruce Hoffman In this month’s edition of CPI Talks we have the pleasure of speaking with Bruce Hoffman of
By Dennis W. Carlton, Mark A. Israel & Allan L. Shampine AT&T/Time Warner is the U.S. Department of Justice’s first
By Steven C. Salop In this short article, I highlight some key issues in formulating revised guidelines and legal standards
© Competition Policy International 2024